More reports from the EAU “Update on Prostate Cancer”

Dr. Zachary Klaassen and UroToday have provided us with four more interesting summaries of presentations by faculty at the European Association for Urology (EAU)’s meeting in Vienna last weekend. … READ MORE …

Next prostate cancer CureTalk on January 20

The next CureTalk program on prostate cancer is scheduled for January 20, 2015, at 5:00 p.m. Eastern time in the USA. The featured speaker is Dr. James Mohler of the Roswell Park Cancer Center in Buffalo, New York. To register for this program, … READ MORE …

Improving diagnosis, prognosis, and treatment decision-making

Whatever one’s views on the relative merits of mass screening or carefully targeted, risk-based testing, there is little doubt that we need to do better in deciding who to biopsy once prostate cancer is suspected and who to treat when it is identified. … READ MORE …

Genomics, prostate cancer, and biomarker development

A number of readers may be interested in an article by Yadav et al. in the January issue of AUA News, entitled “Genomics at the forefront of biomarker development for prostate cancer detection and therapeutics.” … READ MORE …

Reports from the annual meeting of the Society for Urologic Oncology

A series of summary reports from the first day of the 14th annual meeting of the Society for Urologic Oncology (SUO) has recently been made available on the UroToday web site (which is freely accessible to patients, but you do have to register to access it). … READ MORE …

Prostate cancer news reports: Sunday, January 17, 2010

In today’s news reports we address recent publications on:

  • The GEMCaP biomarkers and prediction of prostate cancer recurrence post-surgery
  • Biopsy Gleason score under-staging and active surveillance
  • The value of exercise during radiotherapy
  • Impact of type of surgery on post-surgical continence at 1 year … READ MORE …

New review of biomarkers for prostate cancer detection

Nogueira et al. have just published a new “mini-review” in BJU International that addresses the potential roles of current and “future” biomarkers that may have relevance to prostate cancer detection. … READ MORE …